Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IVERIC bio, Inc. - Common Stock (NQ:ISEE)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 10, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about IVERIC bio, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio to Report Third Quarter 2022 Financial Results and Host Conference Call on Thursday, November 3, 2022
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Watch for Continued Gains in Shares of IVERIC bio Inc. (ISEE)
Via Investor Brand Network
Iveric Bio to Present Top-line Results for Avacincaptad Pegol from Phase 3 GATHER2 Clinical Trial in Geographic Atrophy at AAO 2022 Annual Meeting
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio to Present at Upcoming Investor Conferences
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio (NASDAQ: ISEE) Reports Positive Topline Phase 3 Trial Data for Zimura, Plans to Submit FDA New Drug Application Q1 2023
Iveric Bio, Inc. (NASDAQ: ISEE) is engaged as a biopharmaceutical company, which is focused on the research and development of 
Via Spotlight Growth
Iveric Bio Announces Positive Topline Data from Zimura® GATHER2 Phase 3 Clinical Trial in Geographic Atrophy
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio to Participate in the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio to Present at the Wedbush PacGrow Healthcare Conference 2022
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio Reports Second Quarter 2022 Operational Highlights and Financial Results
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio Announces Agreement for Up to $250 Million in Non-Dilutive Debt Financing with Hercules Capital and Silicon Valley Bank
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio to Report Second Quarter 2022 Financial Results and Host Conference Call on Tuesday, July 26, 2022
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio Announces Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® at American Society of Retina Specialists Meeting
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio and DelSiTech Enter Exclusive Agreement for Development of Sustained Release Zimura®
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio Announces Presentation of Post-Hoc Analysis at Macula Society from GATHER1 Clinical Trial of Zimura® in Patients with Geographic Atrophy
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio to Present at the UBS Global Healthcare Conference 2022
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio to Participate in the H.C. Wainwright Global Investment Conference
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio Reports First Quarter 2022 Operational Highlights and Financial Results
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio Announces Presentation of Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® in Patients with Geographic Atrophy
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From IVERIC Bio, Inc.
Via Business Wire
Iveric Bio to Report First Quarter 2022 Financial Results and Host Conference Call on Wednesday, May 4, 2022
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio to Participate in the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference
From IVERIC bio, Inc.
Via Business Wire
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Iveric Bio
Via Business Wire
Iveric Bio to Present at the Cowen 42nd Annual Health Care Conference
From Iveric Bio
Via Business Wire
Iveric Bio Reports Fourth Quarter and Full Year 2021 Operational Highlights and Financial Results
From IVERIC bio, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.